Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Extends Herbicide Deal with Bayer CropScience

NEW YORK, Nov. 17 (GenomeWeb News) - Paradigm Genetics said today that it has signed a two-year extension of its herbicide discovery collaboration with Bayer CropScience.


This extension, which will take the partnership through Sept. 2006, is the second since the companies began the arrangement, and will include research fees and success fees for assay deliveries. Paradigm also stands to receive royalties from Bayer under the terms of the original deal.


Additional terms were not disclosed.


According to Paradigm, it began in 1998 working to discover novel herbicides that are to be developed and marketed by Bayer CropScience. The term of the inital deal was three years, and included the option for a two-year extension.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more